Cargando…

Hormonal Regulation of Semaphorin 7a Promotes Therapeutic Resistance in Breast Cancer

Background: The majority of all breast cancers (BC) are estrogen receptor positive (ER+). While ER-targeting endocrine therapies have improved patient survival, many of these tumors develop drug resistance and recur within 20 years. Therefore, novel targets are needed to predict for recurrence and t...

Descripción completa

Detalles Bibliográficos
Autores principales: Crump, Lyndsey, Richer, Jennifer K, Porter, Weston, Lyons, Traci
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8089171/
http://dx.doi.org/10.1210/jendso/bvab048.2090